Abstract
The Healthcare sector is known to have experienced various dynamics in the last five years, including during the pandemic since 2020, which has had implications for financial performance and company value. This research aims to examine and analyze the influence of dividend policy, debt policy, and board study diversity on company value. Data was obtained using secondary data from companies in the healthcare sector listed on the Indonesia Stock Exchange for the period 2018 to 2022. Purposive sampling was used as a technique in this research, then a total of 5 final samples of companies were obtained after removing outlier data from the research object. Firm value is measured using the Tobin's Q method. The DPR ratio is used to measure dividend policy, while DER is used to measure debt policy, and Board Study Diversity is measured based on the ratio of board of directors with a background in economics and business studies compared to the total board of directors using panel data regression. Eviews. Test classical assumptions and test hypotheses with partial tests and simultaneous tests. This research explains that dividend policy has a positive and significant effect on company value, debt policy has a negative and significant effect on company value, while Board Study Diversity has no significant effect on company value. It is hoped that the company can improve its investment strategy in the policies it takes to ensure stability and increase company value.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.